This study is for adults and children with blood-related diseases, using special cord blood units (CBUs) that are not approved by the Food and Drug Administration (FDA). Cord blood is blood taken from the umbilical cord after a baby is born, and it can help treat blood diseases. The main goal is to see if blood cells, called neutrophils, recover after using these CBUs. Researchers also want to know about infection risks, serious reactions, survival after one year, and problems like graft vs. host disease (GVHD), where the body attacks the new cells. The study is open to all ages with certain blood disorders. However, people already using FDA-approved CBUs, or those in other studies, can't join.
- The study checks how well non-FDA-approved CBUs work for blood diseases.
- Participants must sign consent and meet specific health criteria.
- No international patients or those using licensed CBUs can join.
How understandable was the trial content above?
Hard to understand
Easy to understand